drug · antibody
patient view →zanidatamab
pre_registrationupdated 2mo agoby $JAZZ Jazz Pharmaceuticals plc🔗 ChEMBL
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and biliary tract neoplasm and 4 investigational indications.
targets
Receptor tyrosine-protein kinase erbB-2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that